NCT07105956View on ClinicalTrials.gov

Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.

Not yet recruitingOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Alzheimer's Disease (AD)
Trial Locations (1)

210006

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT07105956 - Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease. | Biotech Hunter | Biotech Hunter